Excedrin Extra Strength Pain Reliever is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Glaxosmithkline Consumer Healthcare Holdings (us) Llc. The primary component is Acetaminophen; Aspirin; Caffeine.
Product ID | 0067-2000_66c08ddf-952d-4d4b-9b17-e8ea4269445e |
NDC | 0067-2000 |
Product Type | Human Otc Drug |
Proprietary Name | Excedrin Extra Strength Pain Reliever |
Generic Name | Acetaminophen, Aspirin (nsaid), And Caffeine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
Application Number | part343 |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Active Ingredient Strength | 250 mg/1; mg/1; mg/1 |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2006-09-27 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2006-09-27 |
Marketing End Date | 2014-12-31 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Billing Unit | EA |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2006-09-27 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2006-09-27 |
Marketing End Date | 2014-12-31 |
Marketing Category | OTC monograph not final |
Application Number | part343 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2006-09-27 |
Ingredient | Strength |
---|---|
ACETAMINOPHEN | 250 mg/1 |
SPL SET ID: | a71074a6-cc19-4bb3-8c84-4e82a8906801 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI | |
Pharm Class PE | |
PHarm Class EPC | |
NUI Code |
NDC | Brand Name | Generic Name |
---|---|---|
29485-8026 | EXCEDRIN EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN, and CAFFEINE |
29485-8027 | EXCEDRIN EXTRA STRENGTH PAIN RELIEVER | ACETAMINOPHEN, ASPIRIN, and CAFFEINE |
0067-2000 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
0067-2001 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
0067-8202 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
0067-8203 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
53808-0834 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
70518-3399 | Excedrin | Acetaminophen, Aspirin (NSAID), and Caffeine |
52904-868 | Excedrin Extra Strength | acetaminophen, aspirin (nsaid), and caffeine |
0067-8151 | Excedrin Extra Strength and Excedrin Tension Headache | Acetaminophen, Aspirin (NSAID), and Caffeine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXCEDRIN 98594008 not registered Live/Pending |
Haleon CH SARL 2024-06-10 |
EXCEDRIN 97425413 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-05-24 |
EXCEDRIN 97210682 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
EXCEDRIN 97210676 not registered Live/Pending |
GSK Consumer Healthcare SARL 2022-01-10 |
EXCEDRIN 86434099 4978864 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2014-10-24 |
EXCEDRIN 85243455 3985911 Live/Registered |
GSK CONSUMER HEALTHCARE S.A. 2011-02-16 |
EXCEDRIN 74504161 1892912 Dead/Cancelled |
Bristol-Myers Squibb Company 1994-03-23 |
EXCEDRIN 73661685 1472811 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1987-05-18 |
EXCEDRIN 72080162 0696323 Dead/Cancelled |
BRISTOL-MYERS COMPANY 1959-08-25 |